Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.
The safety and efficacy of monoclonal antibody therapy with low-dose bamlanivimab plus etesevimab was similar to that of higher doses of the drug combination in patients with mild to moderate COVID-19 ...
An interim analysis of the phase 2 study evaluated the combination therapy in recently diagnosed patients with mild to moderate COVID-19. New data from the BLAZE-1 clinical trial showed that treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback